Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 18 Source: Estimated
- €514.4 million turnover
- 400 employees
-
31st Dec 17 Source: Estimated
- €321.6 million turnover
- 300 employees
- 4 more years available »
Ranking
By Turnover
(€514.4 million)- 157th in Top Companies
- 22nd in Health
- 19th in Pharma
By Employees
(400)- 417th in Top Companies
- 63rd in Health
- 41st in Pharma
- 400
- €514.4 million
Employees
- Shane Doyle Senior vice president
Latest News
- 2:21pm BT Ireland jobs are safe as group boss gives salary to health workers
- 12:55pm City of London hiring grinds to a halt over Covid-19
- 12:52pm NTMA to sell up to €4bn of debt to help fund State’s response to virus
- 12:42pm JP Morgan rolls our Covid-19 relief measures, may suspend dividend
- 12:34pm Daily Mirror-owner Reach cuts wages, furloughs 20% of staff